Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Pfizer axes another RSV med picked up in $525M ReViral buy
In another blow to its $525 million ReViral buy, Pfizer has ended development of sisunatovir, an oral inhibitor designed to treat RSV.
Gabrielle Masson
Oct 8, 2024 4:58pm
Boehringer inks $607M Circle pact for preclinical cancer program
Oct 9, 2024 8:36am
With Kezar in lupus limbo, Concentra spies potential acquisition
Oct 9, 2024 7:10am
Purespring bottles up $105M series B for kidney gene therapy
Oct 9, 2024 2:00am
GEMMABio gene therapy heads to Brazil with $100M government deal
Oct 8, 2024 1:43pm
Medtronic recalls MiniMed insulin pumps over drained batteries
Oct 8, 2024 12:00pm
Medtech News
FDA clears at-home COVID/flu combo test with eye on fall season
Oct 8, 2024 11:05am
FDA pulse oximeter guidance unlikely to end years of racial bias
Oct 8, 2024 10:58am
Seizure-spotting headset maker Ceribell seeks $101M Nasdaq IPO
Oct 7, 2024 11:30am
MARAbio’s antibody test for autoimmune-related autism nets $19M
Oct 7, 2024 10:00am
See More Medtech News